JPRN-UMIN000005093
Completed
N/A
Clinical study for evaluating immunological efficacy of Glypican-3 peptide vaccine in patients with advanced Hepatocellular carcinoma - Clinical study for evaluating immunological efficacy of GPC3 peptide vaccine in patients with HCC
Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East0 sites20 target enrollmentFebruary 16, 2011
ConditionsHepatocellular Carcinoma (HCC)
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Hepatocellular Carcinoma (HCC)
- Sponsor
- Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Uncontrolled pleural effusion or ascites 2\.There are other malignancies 3\.Active infection excluding HBV, HCV 4\.Clinically significant heart disease (myocardial infarction or unstable angina within the past six months, or uncontrolled cardiac arrhythmias) 5\.There are severe complications including cardiac failure, renal failure, liver failure, active gastro\-duodenal ulcer, ileus, and uncontrolled Diabetes Mellitus 6\.There is severe psychiatric disorder 7\.Pregnant or lactating woman, who are willing to be pregnant 8\.Past history of severe drug allergy 9\.Past history of administration of GPC3 peptide vaccination 10\.Responsible doctors judged the patient in appropriate for the trial
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
A Clinical trial of Omicron-Based CovIran Barkat vaccine as a third injection dose in vaccinated population over 18 years of ageIRCT20171122037571N4SHIFAPHARMED Industrial Group Co210
Recruiting
N/A
Clinical study on the clinical efficacy and immune function of anticancer prescription combined with chemotherapy in patients with bladder cancerITMCTR1900002444Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Completed
N/A
A study for evaluating the immunostimulating effect -A Randomized, double-blind, placebo controlled trial.Healthy adults who feel fatigueJPRN-UMIN000021989ORTHOMEDICO, Inc.40
Completed
N/A
To evaluate effect of immunotherapy .Health Condition 1: - Health Condition 2: C00-C14- Malignant neoplasms of lip, oral cavity and pharynxCTRI/2024/02/062655HCG NCHRI Cancer Centre10
Completed
Phase 3
Sub lingual immunotherapy of Nasal allergiesPerennial allergic rhinitis.Other allergic rhinitisIRCT2017042323235N9Vice chancellor for research, Mashhad University of Medical Sciences40